Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors. 2011

Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.

This study was aimed at evaluating the association between tumor vascularity and other known prognostic factors in different histopathological subtypes of renal cell carcinoma (RCC). In 41 cases of RCC, immunohistochemistry was performed using anti-CD34 antibody and Ki-67 (MIB-1). Microvessel density was estimated in an area of 0.23 mm(2) representative of the highest microvessel density ("hot spot"). The microvessel area (MVA) was expressed as percentage of total tumor area occupied by vessels. Endothelial proliferation index (EPI) was determined from sections stained by Ki-67. The relationship between MVD, MVA, EPI and prognostic parameters of RCC like stage, grade and tumor cells proliferation index (TPI) was evaluated. The tumor MVA increased significantly with the higher stage of the tumor (P < 0.001) and increase in TPI (P < 0.05). The MVD, however, did not show significant correlation with grade and stage of the tumor. Microvessel area appears to be a better prognostic marker for RCC when compared to microvessel density. The increase in MVA, without increase in MVD, with increasing stage may be due to the development of larger diameter vascular channels in higher-stage tumors, and this is thought to facilitate metastasis.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D005260 Female Females

Related Publications

Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
July 1995, Urology,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
November 2004, International journal of urology : official journal of the Japanese Urological Association,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
January 2021, Critical reviews in eukaryotic gene expression,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
June 1994, The American journal of pathology,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
January 2014, International journal of clinical and experimental pathology,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
November 2020, Oncology letters,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
February 2014, International journal of urology : official journal of the Japanese Urological Association,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
December 2014, JPMA. The Journal of the Pakistan Medical Association,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
September 2002, International journal of urology : official journal of the Japanese Urological Association,
Shree Gopal Sharma, and Nidhi Aggarwal, and Siddhartha Datta Gupta, and Manoj Kumar Singh, and Ruchika Gupta, and Amit Kumar Dinda
January 2015, Indian journal of cancer,
Copied contents to your clipboard!